Low level of systemic autoimmunity in Western Australian multiple sclerosis patients

Mult Scler. 2010 Mar;16(3):351-4. doi: 10.1177/1352458509355463. Epub 2010 Feb 11.

Abstract

Previous autoantibody (AAb) studies in multiple sclerosis MS have produced conflicting results. The objective of this study was to determine AAb frequency and association with the HLA-DRB1 genotype. Antinuclear antibody, antithyroid peroxidase and anti-aquaporin-4 assays and HLA-DRB1 genotyping were performed in 198 MS patients and 188 controls. There were no significant differences in AAb frequency or titres between MS and control subjects. AQP4-IgG was not found in any MS patients. There was no correlation between AAbs and HLA-DRB1 alleles. In conclusion, this study failed to confirm previous reports of increased AAbs in MS or to show an association between HLA-DRB1 genotype and the presence of AAbs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Antinuclear / blood
  • Aquaporin 4 / immunology
  • Autoantibodies / blood*
  • Autoimmunity*
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genotype
  • HLA-DR Antigens / genetics
  • HLA-DR Antigens / immunology
  • HLA-DRB1 Chains
  • Humans
  • Logistic Models
  • Male
  • Multiple Sclerosis / ethnology
  • Multiple Sclerosis / genetics
  • Multiple Sclerosis / immunology*
  • Phenotype
  • Risk Assessment
  • Risk Factors
  • Western Australia / epidemiology
  • White People / genetics

Substances

  • AQP4 protein, human
  • Antibodies, Antinuclear
  • Aquaporin 4
  • Autoantibodies
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • thyroid microsomal antibodies